CDC advisers delay planned vote on hepatitis B vaccine for infants

A CDC advisory panel convened to discuss the potential alteration of the recommended birth dose of the hepatitis B vaccine for newborns, a move that could limit access for many low-income families. This decision follows pressure from officials associated with the Trump administration, raising concerns about the implications for public health.

The CDC advisory panel has once again delayed a vote on hepatitis B vaccines, following a tumultuous meeting that raised concerns about misinformation. This postponement continues to stall the decision-making process regarding the vaccination recommendations for newborns.

The CDC's vaccine advisory panel has postponed a crucial vote on hepatitis B vaccines following a tumultuous meeting characterized by misinformation. This delay raises concerns about the decision-making process regarding public health vaccines.

A federal vaccine advisory committee is set to discuss the recommendation for newborns to receive the hepatitis B vaccine, which is currently advised to be administered within 24 hours of birth. This meeting comes as Health Secretary Robert F. Kennedy Jr.'s committee may propose changes that contradict longstanding public health guidelines regarding this cancer-preventing vaccine.

The Centers for Disease Control and Prevention (CDC) is considering a significant change to its vaccination policy, potentially ending the routine administration of the hepatitis B vaccine to newborns within 24 hours of birth. This decision is expected to be voted on by a panel of advisers, reflecting a shift in the long-standing practice of vaccinating infants against this virus.

The CDC's vaccine advisory committee is scheduled to meet on Thursday to discuss potential changes to the childhood vaccination schedule, including the recommendation for universal hepatitis B vaccination for newborns. This meeting reflects a significant shift in the CDC's approach to vaccination protocols.

Advisers to the Centers for Disease Control and Prevention (CDC) are expected to review and potentially alter the long-standing childhood vaccination schedule, a move that could significantly impact public health policy. This scrutiny comes amid rising concerns regarding vaccine messaging and its implications for public trust in health authorities.

A group of advisers at the Centers for Disease Control and Prevention (CDC) is considering reversing the long-standing recommendation for newborns to receive a hepatitis B vaccination within 24 hours of birth. This potential change comes amid ongoing discussions about vaccine protocols and their implications for public health.